Frontlight ResearchEarly access
CompletedNo phase
PCV13 Effectiveness Study Against Hospitalised VT Pneumococcal CAP in Adults 60 Years and Older
Key facts
- Who runs it
- Pfizer
- Where
- Spain5 sites in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 1,821 people enrolled
- Started
- 12 Mar 2021
- Ended
- 24 Mar 2024
- Type of study
- Observational
- Treatments tested
- Urine sample collection
- Saliva collection
- Record updated
- 11 June 2025
Who can take part
- Age
- 60 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 6 criteriaShow less
Who can take part
- Age ≥60 years
- Evidence of pneumonia within first 48 hours of hospital admission
- Evidence of a personally signed and dated informed consent document indicating that the patient (or a legally acceptable representative) has been informed of all pertinent aspects of the study
Who cannot take part
- Previously enrolled subjects readmitted ≤14 days after discharge for their study qualifying admission
- Any patient who develops signs and symptoms of pneumonia after being hospitalized for ≥48 hours (either at current hospital, another transferring hospital, or a combination of these)
- At the time of enrollment, pneumonia has been excluded as the diagnosis or another diagnosis confirmed
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Low interventional, prospective, multicentre, hospital-based study involving adults 60 years of age and older hospitalised with CAP at participating sites.
The group in the trial
- All participants
Treatment: Urine sample collection and Saliva collection
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Low Intervention Study of the Effectiveness Of 13-Valent Pneumococcal Conjugate Vaccine (PCV13) Against Vaccine Type Pneumococcal Hospitalised Community Acquired Pneumonia (CAP) in Adults 60 Years and Older Using A Test Negative Design Study in A Well-Defined Area of the South of Madrid Region
- Record updated
- 11 June 2025